The NIH has long sought to
ensure that the diagnostic and therapeutic research it supports will be of
value to both men and women. For that
reason it has emphasized steps such as full inclusion of females in clinical
trials. Now however, new policies are broadening that mandate to an
unreasonable degree. Not only will
scientists be asked to include females in clinical trials and in more basic
studies using animal models of disease, but they will also be asked to use cell
lines derived from both males and females (1).
(1) http://www.nature.com/news/policy-nih-to-balance-sex-in-cell-and-animal-studies-1.15195
No comments:
Post a Comment